IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 1,900,000 (48%) | — | ₹2,375 Cr |
| Retail | — | 1,900,000 (48%) | — | ₹2,375 Cr |
| Market Maker | — | 200,000 (5%) | — | ₹25 Cr |
| Σ Total | — | 4,000,000 (100%) | — | ₹50,000 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹125,000 |
| Retail (Max) | 13 | 13,000 | ₹1,625,000 |
| S-HNI (Min) | 14 | 14,000 | ₹1,750,000 |
| B-HNI (Min) | 67 | 67,000 | ₹8,375,000 |
Financial Statements Amount in Crore
| Metric | 30-Jun-21 | 31-Mar-21 | 31-Mar-20 |
|---|---|---|---|
| Revenue | 8 | 22 | 22 |
| Profit After Tax | 1 | 2 | 1 |
| Total Assets | 54 | 52 | 45 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Repayment of Loans – 16.00
- 2 Additional Working Capital – 26.00
- 3 General Corporate Expenses – 4.40
- 4 To meet the expenses of the Issue – 3.60
Company Overview
Incorporated in the year 2000, Nidan Laboratories and Healthcare Limited offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. As of March 31, 2021, the company offered approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.
Nidan has come out with a unique appointment booking mobile application under the name of "NIDAN HEALTHCARE" which is supported by self-indigenous software called "Nidan Operation Management (NOM)." This unique app enables patients to book appointments for any test, from anywhere, at any time. The company has also tied up with pathology partners like Metropolis Laboratories Limited for its services.
Out of the 35 centers operating under the brand name of "Nidan Healthcare", 16 centers are under the Franchisee model where 1 center acts as a fully operated diagnostic center and 15 centers act solely as standalone collection centers. As of June 30, 2021, the company had a total of 213 employees. The company has got recognitions like the Best Diagnostic Chain of India Award 2019, in the Category of 20+ diagnostic centers by Express Healthcare.
Competitive Strengths:
- Trusted, high quality, and reliable brand name.
- Customer-centric approach & services
- Location benefits
- Wide range of diagnostic services at affordable prices
- Robust IT technical capabilities with strong IT infrastructure
- Strong and experienced leadership with a dedicated management team